Strata Critical Medical, Inc. (SRTA) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $462.05M | Exchange | NASDAQ |
| Sector | Industrials | Industry | Airlines, Airports & Air Services |
| Country | US | CEO | Melissa Tomkiel |
| IPO Date | 2019-11-05 | CAGR | 35.97% |
| Employees | 327 | Website | www.stratacritical.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $409.84M | P/E | -25.17 | Forward P/E | — | PEG | — |
| P/S | 1.56 | P/B | 1.41 | P/CF | -12.83 | P/FCF | -9.04 |
| Sales | $255.97M | Sales 1Y | 0.64% | Sales 3Y | 34.64% | Sales 5Y | 774.95% |
| EPS | $-0.21 | EPS 1Y | 3.42% | EPS 3Y | -63.8% | EPS 5Y | -48.18% |
| Sales QoQ | 7.6% | EPS QoQ | -533.21% | Sales QoQ Avg | 3.4% | EPS QoQ Avg | -119.57% |
| Gross Margin | 20.56% | Operating Margin | -7.97% | Profit Margin | 15.71% | ROCE | -7.11% |
| ROA | 12% | ROE | 14% | Altman Z Score | 5.19 | Piotroski Score | 2 |
| Current Ratio | 2.64 | Quick Ratio | 2.64 | Cash Ratio | 0.36 | Op. CF Ratio | 0.12 |
| Debt/Equity | 0.02 | Debt/Assets | 0.01 | Lt Debt/Equity | 0.01 | Lt Debt/Cap. | 0.01 |
| Intrst Cov. | — | Inventory Turnover | — | Asset Turnover | 0.77 | Receivables Turnover | 5.9 |
| Enterprise Value | $409.84M | P/E Ratio | -25.17 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 1.56 | P/B Ratio | 1.41 |
| P/CF Ratio | -12.83 | P/FCF Ratio | -9.04 |
| EPS | $-0.21 | EPS Growth 1Y | 3.42% |
| EPS Growth 3Y | -63.8% | EPS Growth 5Y | -48.18% |
| Revenue Growth 1Y | 0.64% | Gross Margin | 20.56% |
| Operating Margin | -7.97% | Profit Margin | 15.71% |
| ROE | 14% | ROA | 12% |
| ROCE | -7.11% | Current Ratio | 2.64 |
| Quick Ratio | 2.64 | Cash Ratio | 0.36 |
| Debt/Equity | 0.02 | Interest Coverage | — |
| Altman Z Score | 5.19 | Piotroski Score | 2 |
Strata Critical Medical, Inc. (SRTA) valuation & financials
Strata Critical Medical, Inc. (SRTA) has a market capitalization of $462.05M and trades at a price-to-earnings ratio of -25.2. It operates in the Industrials sector (Airlines, Airports & Air Services).
Strata Critical Medical, Inc.'s revenue grew +0.6% over the last year.
Strata Critical Medical, Inc.'s next earnings report is scheduled for November 9, 2026 before market open (provider scheduled date); analysts estimate EPS of $0.01. Check the earnings calendar to see all companies reporting this week.
Compare with other Industrials companies: Caterpillar (CAT) · General Electric (GE) · Raytheon Technologies (RTX) · Siemens (SIE.DE) · CATL (300750.SZ) · Schneider Electric (SU.PA)